Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Endonovo Therapeutics Inc (ENDV)

Endonovo Therapeutics Inc (ENDV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Endonovo Therapeutics Inc 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 USA

P: 800-489-4774

Description:

Endonovo Therapeutics, Inc. is a biotechnology company which is engaged in developing a bioelectronic approach to regenerative medicine. The company's Immunotronics(TM) platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation and necrosis, and the promotion of regeneration. Endonovo's Cytotronics(TM) platform provides method of expanding and manipulating cells using simulated microgravity and Time-Varying Electromagnetic Fields for tissue engineering and cell therapies. Endonovo Therapeutics, Inc. is headquartered in Woodland Hills, California.

Key Statistics

Overview:

Market Capitalization, $K 1,303
Shares Outstanding, K 1,002,549
Annual Sales, $ 80 K
Annual Net Income, $ -6,440 K
Last Quarter Sales, $ 50 K
Last Quarter Net Income, $ -1,410 K
60-Month Beta 2.12
% of Insider Shareholders 5.61%
% of Institutional Shareholders 0.00%
Float, K 946,306
% Float 94.39%

Growth:

1-Year Return -93.50%
3-Year Return -97.89%
5-Year Return -99.93%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/19/19
Earnings Per Share ttm -0.01
EPS Growth vs. Prev Qtr 100.00%
EPS Growth vs. Prev Year 100.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-100 on 06/27/14

ENDV Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 0.00
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) 0.00
Return-on-Assets (Before Tax) -264.21
Profit Margin % -8,050.00
Net Margin % N/A
Debt/Equity N/A
Price/Sales 6.86
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.02
Interest Coverage -0.24
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar